{"chunk_id": "medquad__chunk_3886", "source": "medquad", "text": "Nivolumab: Nivolumab is a monoclonal antibody that boosts the bodys immune response against renal cell cancer cells.     -  Interferon: Interferon affects the division of cancer cells and can slow tumor growth.     -  Interleukin-2 (IL-2): IL-2 boosts the growth and activity of many immune cells, especially lymphocytes (a type of white blood cell). Lymphocytes can attack and kill cancer cells.           See Drugs Approved for Kidney (Renal Cell) Cancer for more information.       Targeted ther"}